Analyst Price Targets — TMO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 3, 2026 9:46 am | Michael Luo | CLSA | $748.00 | $608.54 | TheFly | Thermo Fisher initiated with an Outperform at CLSA |
| August 5, 2026 11:09 am | — | Stifel Nicolaus | $650.00 | $564.75 | TheFly | Thermo Fisher price target raised to $650 from $600 at Stifel |
| July 27, 2026 11:09 am | — | Piper Sandler | $600.00 | $568.26 | TheFly | Thermo Fisher price target raised to $600 from $510 at Piper Sandler |
| July 24, 2026 8:00 pm | — | Morgan Stanley | $650.00 | $568.26 | TheFly | Thermo Fisher price target raised to $650 from $620 at Morgan Stanley |
| July 24, 2026 12:43 pm | Dan Leonard | RBC Capital | $580.00 | $561.09 | TheFly | Thermo Fisher price target raised to $580 from $490 at RBC Capital |
| July 23, 2026 6:09 pm | Tycho Peterson | Jefferies | $630.00 | $572.60 | TheFly | Thermo Fisher price target raised to $630 from $585 at Jefferies |
| July 6, 2026 12:48 pm | — | Evercore ISI | $570.00 | $511.31 | TheFly | Thermo Fisher price target lowered to $570 from $575 at Evercore ISI |
| June 26, 2026 10:26 am | — | Bernstein | $520.00 | $505.75 | TheFly | Thermo Fisher resumed with a Market Perform at Bernstein |
| June 11, 2026 9:52 am | — | Piper Sandler | $510.00 | $482.04 | TheFly | Thermo Fisher initiated with a Neutral at Piper Sandler |
| June 3, 2026 7:12 am | Sidharth Sahoo | HSBC | $540.00 | $482.08 | StreetInsider | HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold |
Latest News for TMO
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance. Laboratories performing…
Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.
Beacon Pointe Advisors LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 37,709 shares of the medical research company's stock, valued at approximately $18,906,000. Several other hedge funds also recently modified their holdings of
Ausdal Financial Partners Inc. bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 910 shares of the medical research company's stock, valued at approximately $456,000. Several other hedge funds and other
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.